Protect Yourself While There’s Still Time …

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

Joel Lebowitz Biography and Net Worth

CFO of Schrödinger

Joel Lebowitz, Executive Vice President and Chief Financial Officer, joined Schrödinger in 2018. Joel has extensive experience in the pharmaceutical industry. In 26 years at Merck, he held finance leadership positions in pharmaceutical R&D portfolio analysis, financial planning and analysis, reporting, financing and investing, business development, project management, and financial evaluation. He holds a BA in Applied Mathematics and Economics from Brown University and an MBA in Finance and International Business from Columbia Graduate School of Business.

What is Joel Lebowitz's net worth?: The estimated net worth of Joel Lebowitz is at least $133,608.78 as of July 14th, 2021. Mr. Lebowitz owns 5,574 shares of Schrödinger stock worth more than $133,609 as of April 27th. This net worth evaluation does not reflect any other assets that Mr. Lebowitz may own. Learn More about Joel Lebowitz's net worth.
How do I contact Joel Lebowitz?: The corporate mailing address for Mr. Lebowitz and other Schrödinger executives is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. Schrödinger can also be reached via phone at 212-295-5800 and via email at [email protected]. Learn More on Joel Lebowitz's contact information.
Has Joel Lebowitz been buying or selling shares of Schrödinger?: Joel Lebowitz has not been actively trading shares of Schrödinger over the course of the past ninety days. Most recently, Joel Lebowitz sold 5,574 shares of the business's stock in a transaction on Wednesday, July 14th. The shares were sold at an average price of $68.04, for a transaction totalling $379,254.96. Following the completion of the sale, the chief financial officer now directly owns 5,574 shares of the company's stock, valued at $379,254.96. Learn More on Joel Lebowitz's trading history.
Who are Schrödinger's active insiders?: Schrödinger's insider roster includes Robert Abel (Insider), Karen Akinsanya (Insider), Rosana Kapeller-Libermann (Director), Joel Lebowitz (CFO), David Shaw (Major Shareholder), Yvonne Tran (EVP), and Jorg Weiser (Director). Learn More on Schrödinger's active insiders.
Are insiders buying or selling shares of Schrödinger?: During the last twelve months, insiders at the sold shares 8 times. They sold a total of 48,501 shares worth more than $1,943,224.69. The most recent insider tranaction occured on February, 12th when EVP Yvonne Tran sold 758 shares worth more than $21,443.82. Insiders at Schrödinger own 7.6% of the company. Learn More about insider trades at Schrödinger.
Information on this page was last updated on 2/12/2024.

Joel Lebowitz Insider Trading History at Schrödinger

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/14/2021	Sell	5,574	$68.04	$379,254.96	5,574
6/14/2021	Sell	5,574	$77.36	$431,204.64	5,574
5/18/2021	Sell	5,574	$64.45	$359,244.30	5,574
4/14/2021	Sell	5,574	$78.43	$437,168.82	5,574
3/15/2021	Sell	5,574	$79.96	$445,697.04	5,574
2/5/2021	Sell	11,259	$99.08	$1,115,541.72	12,374
11/23/2020	Sell	16,722	$64.90	$1,085,257.80	16,722
8/19/2020	Sell	117,051	$67.77	$7,932,546.27	117,051

Joel Lebowitz Buying and Selling Activity at Schrödinger

Schrödinger Company Overview

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Today's Range

Now: $23.97

$23.36

$24.27

50 Day Range

MA: $26.77

$23.34

$33.09

2 Week Range

Now: $23.97

$20.76

$59.24

Volume

710,860 shs

Average Volume

626,080 shs

Market Capitalization

$1.73 billion

P/E Ratio

38.05

Dividend Yield

N/A

Beta

1.57